Development of a New TROP-2 ADC with Better Therapeutic Window

Time: 10:10 am
day: Day One


  • TROP has emerged as an appealing target for ADC development
  • Tackling the unique challenge for a target with larger tissue distribution and utilization of weaker payload
  • Witnessing how novel ADC design has achieved better linker stability, which has greatly reduced ADC toxicity and improved therapeutic window